Antioxidative Effects of Lycium chinense Miller on Cisplatin-induced Nephrotoxicity in Rats
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives : Cisplatin is a widely used cancer therapy drug. However, nephrotoxicity resulting in increased oxidative stress is a major side effect of cisplatin chemotherapy, thereby limiting its chemotherapeutic use. Lycium chinense Miller (LCM) has been used as a traditional herbal medicine in various febrile and inflammatory diseases such as night sweat, cough, nosebleed, bronchitis, pulmonary tuberculosis, etc. In this study we investigated the protective and antioxidative potential of LCM against cisplatin-induced nephrotoxicity in rats. Methods : Twenty-four 8-week-old male Wistar rats were divided into four groups: normal untreated; cisplatin treatment only; LCM 10 mg/kg plus cisplatin treatment; and LCM 30 mg/kg plus cisplatin treatment. Twenty-four hours after the last cisplatin injection, all the rats were sacrificed, and serological changes were evaluated. The levels of NF-κB activity and NOX-4, p47phox, p22phox, COX-2, iNOS, SOD, catalase expressions were analyzed in Western blot analysis. Results : Cisplatin injection caused an increase in the BUN level, which is a reliable indicator of renal toxicity. The levels of BUN, renal ROS, and renal TBARS were significantly reduced in the LCM groups compared with the cisplatin-only groups. The levels of p47phox and p22phox, which are NADPH oxidase subunits, were increased in the cisplatin-only groups, whereas they were decreased in the LCM groups. The levels of renal NF-κB activity and COX-2, iNOS expressions were increased significantly in the cisplatin-only groups compared with the normal groups, whereas they were decreased in the LCM groups. Compared with the cisplatin-only groups, renal GSH and GSH/GSSG increased in the LCM groups. Also, the administration of LCM increased levels of SOD and catalase as compared with the cisplatin-only groups. Conclusions : These results suggest that LCM protects cisplatin-induced nephrotoxicity via a mechanism that may involves the inhibition of oxidative stress by the activation of antioxidants.
Abstract
Objectives : Cisplatin is a widely used cancer therapy drug. However, nephrotoxicity resulting in increased oxidative stress is a major side effect of cisplatin chemotherapy, thereby limiting its chemotherapeutic use. Lycium chinense Miller (LCM) has been used as a traditional herbal medicine in various febrile and inflammatory diseases such as night sweat, cough, nosebleed, bronchitis, pulmonary tuberculosis, etc. In this study we investigated the protective and antioxidative potential of LCM against cisplatin-induced nephrotoxicity in rats. Methods : Twenty-four 8-week-old male Wistar rats were divided into four groups: normal untreated; cisplatin treatment only; LCM 10 mg/kg plus cisplatin treatment; and LCM 30 mg/kg plus cisplatin treatment. Twenty-four hours after the last cisplatin injection, all the rats were sacrificed, and serological changes were evaluated. The levels of NF-κB activity and NOX-4, p47phox, p22phox, COX-2, iNOS, SOD, catalase expressions were analyzed in Western blot analysis. Results : Cisplatin injection caused an increase in the BUN level, which is a reliable indicator of renal toxicity. The levels of BUN, renal ROS, and renal TBARS were significantly reduced in the LCM groups compared with the cisplatin-only groups. The levels of p47phox and p22phox, which are NADPH oxidase subunits, were increased in the cisplatin-only groups, whereas they were decreased in the LCM groups. The levels of renal NF-κB activity and COX-2, iNOS expressions were increased significantly in the cisplatin-only groups compared with the normal groups, whereas they were decreased in the LCM groups. Compared with the cisplatin-only groups, renal GSH and GSH/GSSG increased in the LCM groups. Also, the administration of LCM increased levels of SOD and catalase as compared with the cisplatin-only groups. Conclusions : These results suggest that LCM protects cisplatin-induced nephrotoxicity via a mechanism that may involves the inhibition of oxidative stress by the activation of antioxidants.
참고문헌 (29)
- "The Herbal medicine compilation committee of Oriental medicine college. Herbal medicine", pp.279~281 (2006), Younglim Publishing
- Hwang DY, "Bang-yak-hap-pyeon", pp.154~ (1978), Yeong- rim-sa
- Kim YH, "Cheong-gam-ui-gam", pp.103~106 (1984), Seong-bo-sa
- Shin MG, "Clinical Herbal medicine", pp.302~ (1986), Nam -san-dang
- Ann DG, "Illustrated Book of Korean Medicinal Herbs", pp.678~ (1998), Kyo-Hak Publishing Co., Ltd
- 최규호, "地骨皮가 H₂O₂에 의한 LLC-PK₁ 세포의 Redox Status 및 NF-κB Signaling에 미치는 영향", 대한한방내과학회지, 30(1), pp.36~50 (2009), 대한한방내과학회
- 안병용, "자외선 B에 노출된 쥐 표피의 지질과산화에 대한 지골피 물 추출물의 보호효과", Applied Biological Chemistry, 45(4), pp.218~222 (2002), 한국응용생명화학회
- Boulikas T, "Cisplatin and platinum drugs at the molecular level (Review)", Oncol Rep, 10, pp.1663~1682 (2003)
- Luke DR, "Lopez-Berestein G. Role of vascular congestion in cisplatin-induced acute renal failure in the rat", Nephrol Dial Transplant, 37(1), pp.1~7 (1992)
- Lee S, "Protective role of L-2-oxothiazolidine -4-carboxylic acid in cisplatin-induced renal injury", Nephrol Dial Transplant, 21, pp.2085~2095 (2006)
- Cetil R, "Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods", J Appl Toxicol, 26, pp.42~46 (2006)
- Rosa Martha Perez Gutierrez, "Nephroprotective Activity of Prosthechea michuacana Against Cisplatin-Induced Acute Renal Failure in Rats", Journal of Medicinal Food, 13(4), pp.911~916 (2010), 한국식품영양과학회
- Zitka O, "Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients", Oncology Letters, 4, pp.1247~1253 (2012)
- Farber JL, "Mechanism of cell injury by activated oxygen species", Lab Invest, 62, pp.670~679 (1990)
- Kilic U, "Melatonin suppress cisplatin- induced nephrotoxicity via activation of Nrf-2", HO-1 pathway, 2013, pp.10(7), 1~8
- Davis CA, "Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide", J Am Soc Nephrol, 12(12), pp.2683~2690 (2001)
- Ebadi M, "Oxidative stress and antioxidant theory in Parkinson's disease", Progression in Neurobiology, 48, pp.1~19 (1996)
- Jenner P, "Oxidative stress and the pathogenesis of Parkinson's disease", Neurology, 47, pp.161~176 (1996)
- Simonian NA, "Oxidative stress in neurodegenerative disease", Annual Review of Pharmacological Toxicology, 36, pp.83~106 (1996)
- Penta AD, "Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation", PLoS ONE, 8(2), pp.1~13 (2013)
- Lambeth JD, "Nox enzymes and the biology of reactive oxygen", Nat Rev Immunol, 4, pp.181~189 (2004)
- Yu BP, "Aging and oxidative stress: modulation by dietary restriction", Free Radic Bilo Med, 21, pp.651~668 (1996)
- Kim DH, "Molecular Study of Dietary Heptadecane for the Anti-Inflammatory Modulation of NF-kB in the Aged Kidney", PLOS ONE, 8(3) (2013), PUBLIC LIBRARY SCIENCE
- Siebenlist U, "Structure, regulation and function of NF-κB", Annual Review of Cell Biology, 10, pp.405~455 (1994)
- Baldwin AS, "NF-kappa B and I kappa B proteins: new discoveries and insights", Annu Rev Immunol, 14, pp.649~683 (1996)
- har RV, "Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation", Am J Clin Nutr, 94, pp.847~853 (2011)
- Johnson WM, "Dysregulation of glutathione homeostasis in neurodegenerative diseases", Nutirents, 4, pp.1399~1440 (2012)
- Townsend DM, "The importance of glutathione in human disease", Biomedicine and Pharmacotherapy, 57, pp.145~155 (2003)
- Freeman BA, "Biology of disease: free radicals and tissue injury", Lab Invest, 47, pp.412~426 (1982)